Eton Pharmaceuticals (ETON) Assets Average (2018 - 2026)

Eton Pharmaceuticals has disclosed Assets Average across 9 years of filings, most recently posting $104.0 million for Q2 2026.

• In Q2 2026, Assets Average rose 11.96% year-over-year to $104.0 million; the TTM figure through Jun 2026 stood at $104.0 million (up 11.96% YoY), while the FY2025 annual figure was $84.1 million, up 55.97% from the prior year.
• Assets Average came in at $104.0 million for Q2 2026 at Eton Pharmaceuticals, up from $98.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $104.0 million in Q2 2026 to a low of $22.3 million in Q3 2022.
• Average Assets Average over 5 years is $49.4 million, with a median of $31.3 million recorded in 2024.
• Year-over-year, Assets Average dropped 24.31% in 2022 and jumped 204.72% in 2025.
• Over 5 years, Assets Average stood at $23.3 million in 2022, then surged by 35.91% to $31.6 million in 2023, then jumped by 76.97% to $56.0 million in 2024, then jumped by 75.61% to $98.3 million in 2025, then gained by 5.75% to $104.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $104.0 million in Q2 2026, $98.3 million in Q4 2025, and $103.1 million in Q3 2025.